Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1175 of 1863 entries
View as:

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT00597519 Org: User:
Start: 03/31/06 End: 09/30/15 Due: 09/30/16

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00357396 Org: User:
Start: 06/30/05 End: 10/31/09 Due: 10/31/10

Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02309580 Org: User:
Start: 01/31/15 End: 05/08/23 Due: 05/08/24

Imaging Brain Tumors With FACBC and Methionine

Phase: N/A Priority: Normal
NCT ID: NCT00597246 Org: User:
Start: 05/13/03 End: 11/27/19 Due: 11/27/20

Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT05182112 Org: User:
Start: 12/20/21 End: 11/04/24 Due: 11/04/25

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04298086 Org: User:
Start: 03/04/20 End: 03/31/26 Due: 03/31/27

PET Scans in Patients With Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00109785 Org: User:
Start: 03/31/97 End: 12/31/08 Due: 12/31/09

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06007924 Org: User:
Start: 08/16/23 End: 08/16/27 Due: 08/16/28

Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population

Phase: N/A Priority: Normal
NCT ID: NCT00615147 Org: User:
Start: 05/31/05 End: 06/30/08 Due: 06/30/09

A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

Phase: N/A Priority: Normal
NCT ID: NCT04872543 Org: User:
Start: 04/29/21 End: 04/30/26 Due: 04/30/27

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00006039 Org: User:
Start: 12/31/99 End: 03/31/01 Due: 03/31/02

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00072358 Org: User:
Start: 07/31/03 End: 01/15/21 Due: 01/15/22

Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00087282 Org: User:
Start: 06/30/04 End: 07/31/06 Due: 07/31/07

Research on the Environment and Children's Health: Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00582049 Org: User:
Start: 08/31/03 End: 06/30/08 Due: 06/30/09

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03377387 Org: User:
Start: 12/13/17 End: 12/31/26 Due: 12/31/27

Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00968500 Org: User:
Start: 08/31/09 End: 08/31/25 Due: 08/31/26

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Phase: N/A Priority: Normal
NCT ID: NCT04143516 Org: User:
Start: 10/25/19 End: 10/31/26 Due: 10/31/27

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003430 Org: User:
Start: 04/30/98 End: 04/30/00 Due: 04/30/01

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT00006245 Org: User:
Start: 07/31/00 End: 08/31/07 Due: 08/31/08

Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy

Phase: N/A Priority: Normal
NCT ID: NCT01551433 Org: User:
Start: 02/29/12 End: 08/31/16 Due: 08/31/17

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06312124 Org: User:
Start: 03/08/24 End: 03/08/28 Due: 03/08/29

Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02437071 Org: User:
Start: 04/30/15 End: 09/20/24 Due: 09/20/25

Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation

Phase: N/A Priority: Normal
NCT ID: NCT01157767 Org: User:
Start: 05/11/10 End: 08/23/21 Due: 08/23/22

Assessment of the Functional Significance of Accessory Pudendal Arteries

Phase: N/A Priority: Normal
NCT ID: NCT00577876 Org: User:
Start: 09/30/06 End: 10/31/11 Due: 10/31/12

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT02570542 Org: User:
Start: 10/31/15 End: 10/31/25 Due: 10/31/26